Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Letter

Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis

Authors

J Narváez PubMed articles Google scholar articles
C Díaz-Torné PubMed articles Google scholar articles
X Juanola PubMed articles Google scholar articles
C Geli PubMed articles Google scholar articles
J M Llobet PubMed articles Google scholar articles
J M Nolla PubMed articles Google scholar articles
C Díaz-López PubMed articles Google scholar articles

Dr F J Narváez García, Department of Rheumatology (planta 10–2), Hospital Universitario de Bellvitge, Feixa Llarga s/n 08907, L’Hospitalet de Llobregat, Barcelona, Spain; 31577edd{at}comb.es

Citation

Narváez J, Díaz-Torné C, Juanola X, et al

Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis

Annals of the Rheumatic Diseases 2009;68:607-608.

Publication history

Accepted July 26, 2008
First published March 13, 2009.

Online issue publication

September 19, 2019

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism